Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06446206
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-06
First Post:
2024-05-22
Brief Title:
Adebrelimab Plus Chemotherapy Bevacizumab and Fluzoparib in Platinum-Sensitive Relapsed Ovarian Cancer
Sponsor:
The First Hospital of Jilin University
Organization:
The First Hospital of Jilin University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Platinum-sensitive Relapsed Ovarian Cancer |
Keywords: